Clinical Trials

120 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06767982 2025-01-10

Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

Phase 4 Completed

160 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04806178 2024-12-09

IMMUNOBCG

30 enrolled

Urinary Bladder Neoplasms

NCT00070070 2022-10-12

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

6 enrolled 7 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00694915 2021-08-17

STCC

122 enrolled

Urinary Bladder Neoplasms

NCT01373294 2019-08-06

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

17 enrolled 8 charts

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms

NCT02326168 2017-01-25

PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer

25 enrolled

Urinary Bladder Neoplasms

NCT01498172 2015-02-04

BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

23 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00002490 2013-12-18

Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms

NCT00427570 2013-06-24

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00002990 2013-06-12

Surgery and BCG in Treating Patients With Bladder Cancer

1,288 enrolled

Urinary Bladder Neoplasms

NCT00016133 2013-05-30

Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

Phase 1/2 Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003184 2013-04-04

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Breast

Breast Neoplasms

NCT00004122 2013-02-01

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms

NCT00003759 2013-01-31

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Urinary Bladder Neoplasms

NCT00003023 2013-01-18

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

24 enrolled

CNSSarcoma

Neuroblastoma, Sarcoma, Osteosarcoma

NCT00023842 2012-09-24

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

97 enrolled

Urinary Bladder Neoplasms

NCT00006352 2012-07-18

Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer

453 enrolled

Thoracic

Lung Neoplasms

NCT00003279 2012-03-06

SILVA

500 enrolled

Thoracic

Lung Neoplasms

NCT01442519 2011-09-28

BCG/EMDA-MMC

212 enrolled

Urinary Bladder Neoplasms

NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Phase 2/3 Completed

140 enrolled